Carcinoma In Situ and p16 Status of Head and Neck Squamous Cell Carcinomas

被引：0
|
作者：
Jo, V. Y. [1 ]
O'Connor, S. M. [1 ]
Stoler, M. H. [1 ]
Stelow, E. B. [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1231
引用
收藏
页码：274A / 275A
页数：2
相关论文
共 50 条
  • [31] IS P16 IMMUNOHISTOCHEMISTRY A SURROGATE FOR THE PRESENCE OF AN HPV INFECTION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA?
    Weynand, B.
    Vanhaebost, J.
    Guiot, Y.
    Gregoire, V.
    Machiels, J. P.
    Reychler, H.
    Hamoir, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S10 - S10
  • [32] The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma
    da Costa, Alexandre A. B. A.
    Costa, Felipe D'Almeida
    Araujo, Daniel Vilarim
    Guedes Camandaroba, Marcos Pedro
    Fonseca de Jesus, Victor Hugo
    Oliveira, Audrey
    Fonseca Alves, Ana Caroline
    Stecca, Carlos
    Machado, Larissa
    Feraz de Oliveira, Andrea Cruz
    de Oliveira, Thiago Bueno
    Nicolau, Ulisses Ribaldo
    Cordeiro de Lima, Vladmir Claudio
    MEDICAL ONCOLOGY, 2019, 36 (01)
  • [33] p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro
    Liggett, WH
    Sewell, DA
    Rocco, J
    Ahrendt, SA
    Koch, W
    Sidransky, D
    CANCER RESEARCH, 1996, 56 (18) : 4119 - 4123
  • [34] p16 and p53 expression status in head and neck squamous cell carcinoma: a correlation with histological, histoprognostic and clinical parameters
    Karpathiou, Georgia
    Monaya, Alessandra
    Forest, Fabien
    Froudarakis, Marios
    Casteillo, Francois
    Dumollard, Jean Marc
    Prades, Jean Michel
    Peoc'h, Michel
    PATHOLOGY, 2016, 48 (04) : 341 - 348
  • [35] Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status
    Abi-Raad, Rita
    Prasad, Manju L.
    Gilani, Syed
    Garritano, James
    Barlow, Deborah
    Cai, Guoping
    Adeniran, Adebowale J.
    CANCER CYTOPATHOLOGY, 2021, 129 (05) : 394 - 404
  • [36] Outcome and molecular features of head and neck squamous cell carcinomas (HNSCC) bearing a p16 high phenotype
    Psyrri, D.
    Pectasides, E.
    Weinberger, P.
    Sasaki, C.
    Burtness, B.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] p16 immunocytochemistry on aspirate smears of neck masses: Another option for determining the HPV status in metastatic head and neck squamous cell carcinoma
    Griffith, Christopher C.
    CANCER CYTOPATHOLOGY, 2019, 127 (07) : 423 - 425
  • [38] The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma
    Xu, Bin
    Ghossein, Ronald
    Lane, Jason
    Lin, Oscar
    Katabi, Nora
    HUMAN PATHOLOGY, 2016, 54 : 193 - 200
  • [39] The Prevalence and Prognostic Value of p16 in Non-Oropharyngeal Head and Neck Squamous Cell Carcinoma
    Wang, X.
    Yin, Z.
    Wang, P.
    Wang, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E385 - E385
  • [40] Genetic and epigenetic alteration profiles for p16 in head and neck squamous cell carcinoma in young adults
    O'Regan, EM
    Fan, CY
    Toner, ME
    Ring, M
    Finn, SP
    Timon, C
    Smyth, P
    Cahill, S
    Sheils, O
    O'Leary, JJ
    LABORATORY INVESTIGATION, 2006, 86 : 210A - 210A
12345